Scientific letter N°3

ATLANCHIM PHARMA celebrated first birthday on the 18th of April 2009 and it seems that this takeover is characterized by a positive and encouraging assessment thanks to all of you : customers, partners, scientific team,… Indeed, despite the hard times of 2007/2008, our customers keep on entrusting us with regularly-requested studies thanks to a scientific team remained unchanged and also its strong desire of success. We also have extended our customers’ portfolio by exporting intensively our services abroad.
We are currently restructuring and ATLANCHIM PHARMA is about to enlarge its production capacity by 50% in order to increasingly give satisfaction to all customers.
Then still in a continuous-improvement spirit, we have recently purchased some new equipment in chemistry (continuous-flow hydrogenation reactor, CEM Discover LabMate – Research Scale
Synthesizers Microwave, preparative chromatography) in order to be even more efficient and to carry out syntheses even more quickly.
Furthermore we now have partners (service providers) in order to extend our range of analytical services associated to the custom-made chemical synthesis of complex molecules.
Finally the synergy of ATLANCHIM PHARMA and ATLANTIC BONE SCREEN (specialized in preclinical evaluation of compounds in the field of bone and joint diseases) allows the proposition of global and customized solutions and contributes towards both companies’success.
In this scientific letter, you will be up to appreciate the portrait of another chemistry-biology team on the last scientific letter model.
You will also find a description of the equipments recently purchased.
ATLANCHIM PHARMA team and I wish you an enjoyable reading of this scientific letter.

Ronan LE BOT
Directeur